Biocorrx (OTCMKTS:BICX) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Biocorrx (OTCMKTS:BICX) released its quarterly earnings data on Friday. The company reported ($0.03) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports.

Biocorrx Stock Down 45.7%

Shares of OTCMKTS BICX traded down $0.13 during mid-day trading on Friday, reaching $0.15. 23,798 shares of the company were exchanged, compared to its average volume of 6,947. The stock has a market cap of $4.52 million, a price-to-earnings ratio of -0.95 and a beta of 0.19. Biocorrx has a 1 year low of $0.15 and a 1 year high of $1.28. The firm has a 50-day moving average of $0.32 and a 200 day moving average of $0.35.

About Biocorrx

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.